To assess the incidence of vitamin D deficiency in patients receiving OHA, with comparison of metformin vs non-metformin groups
1 Post-graduate, Department of General Medicine, G.S. Medical College and Hospital, Hapur, UP, India.
2 Assitant Professor, Department of General Medicine, G.S. Medical College and Hospital, Hapur, UP, India.
3 Professor, Department of General Medicine, G.S. Medical College and Hospital, Hapur, UP, India.
Research Article
International Journal of Frontiers in Medicine and Surgery Research, 2024, 05(02), 007–012.
Article DOI: 10.53294/ijfmsr.2024.5.2.0031
Publication history:
Received on 03 February 2024; revised on 25 March 2024; accepted on 28 March 2024
Abstract:
If gastrointestinal symptoms from metformin use can create an environment conducive to the malabsorption of vitamin B12, it Is probable that vitamin D could also be malabsorbed. This could adversely affect treatment efficacy as well as expose certain patient populations to the risk of symptoms of vitamin D deficiency. Currently, no published studies have examined the effect of metformin on vitamin D levels in a population of patients with diabetes.
Hence, this study focuses on the incidence of deficiencies of vitamin D in patients with type 2 diabetes on treatment with metformin (Biguanide) and compare with those on other OHAs.
Keywords:
Buguanide; Hypovitaminosis D; Fatigue; Type 2 diabetes mellitus
Full text article in PDF:
Copyright information:
Copyright © 2024 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0